Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E3810 (Pariet) in Non-Erosive Gastroesophageal Reflux Disease
NCT00165672Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in Non-erosive Gastroesophageal Reflux Disease (NERD), sponsored by Eisai Co., Ltd.. Started May 2005; status: completed.
02
Drugs
rabeprazole
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on NCT00165672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165672.